AC Immune SA (ACIU) Stock: Buy, Sell, or Hold?
ACIU - AC Immune SA
$2.42
-0.08 (-3.20%)
▼
5d:
+1.26%
30d:
-9.02%
90d:
+5.22%
BUY
HIGH Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 03, 2026
10d
Get Alerted When ACIU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ACIU trading at deep discount. Market pricing in -23.6% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: ACIU trading at deep discount. Market pricing in -23.6% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.85
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.87
50.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ACIU is currently trading at $2.42, which is considered oversold relative to its 30-day fair value range of $2.46 to $2.70. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.0) compared to its historical average (11.3). Remarkably, the market is currently pricing in an annual earnings decline of 23.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ACIU is in a uptrend. The price is currently testing key support at $2.35. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: ACIU scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.66 (+246.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ACIU is in a uptrend. The price is currently testing key support at $2.35. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: ACIU scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.66 (+246.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.46 -
$2.70
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
85.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (74/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 246.2% below Wall St target ($8.66)
- BULLISH: Bottoming setup score 74/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$2.46 -
$2.70
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.35
Resistance Level
$2.53
Current Trend
Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.04
Wall Street Target
$8.66
(+246.2%)
Revenue Growth (YoY)
1057.2%
Profit Margin
-246.5%
Valuation Discount vs History
-23.6% cheaper
PE vs Historical
5.0 vs 11.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-23.6%
(market-implied from PE analysis)
1-Year Target
$2.25
(-10%)
2-Year Target
$2.02
(-19%)
3-Year Target
$1.82
(-27%)
3-Yr Target (if PE normalizes)
(PE: 5→11)
$4.08
(+63%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.0 to 11.3
Stabilization Target:
$5.60
(+124.1%)
PE Expansion Potential:
+124.1%
Share & Embed Analysis
Last updated: October 23, 2026 3:59 PM ET
Data refreshes hourly during market hours. Next update: 4:59 PM
Data refreshes hourly during market hours. Next update: 4:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACIU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$197 | 53 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 64 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$686 | 48 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
16 analysts |
$35 | 59 HOLD |
|
CGON
CG Oncology, Inc. Common… |
STRONG BUY
15 analysts |
$91 | 64 BUY |
